Novira Therapeutics

Novira Therapeutics was a biopharmaceutical company developing direct-acting antivirals for chronic hepatitis B (HBV), notably HBV capsid assembly modulators. It was acquired by Johnson & Johnson (Janssen) in 2015 and no longer operates as an independent entity. Its domain (noviratherapeutics.com) is now run on Johnson & Johnson DNS and mail infrastructure with no public website, developer portal, or API. Surfaced as a portfolio company of canaan-partners; the enrichment pipeline confirms there is no API or developer surface to catalog.

Novira Therapeutics is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Pharmaceuticals, Hepatitis B, and Antivirals.

🌐 Visit website 📡 Source on GitHub

6.8/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5

0 APIs

CompanyBiotechnologyPharmaceuticalsHepatitis BAntiviralsAcquired

Kin Score

Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5

Composite quality — 6.8/100 · minimal

Contract Quality 0.0 / 25

Developer Ergonomics 0.0 / 20

Commercial Clarity 0.0 / 20

Operational Transparency 0.0 / 13

Governance 0.0 / 12

Discoverability 6.8 / 10

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 15

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/novira-therapeutics: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Source (apis.yml)

aid: novira-therapeutics
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/novira-therapeutics.png
name: Novira Therapeutics
description: Novira Therapeutics was a biopharmaceutical company developing direct-acting antivirals for chronic hepatitis
  B (HBV), notably HBV capsid assembly modulators. It was acquired by Johnson & Johnson (Janssen) in 2015 and no longer operates
  as an independent entity. Its domain (noviratherapeutics.com) is now run on Johnson & Johnson DNS and mail infrastructure
  with no public website, developer portal, or API. Surfaced as a portfolio company of canaan-partners; the enrichment pipeline
  confirms there is no API or developer surface to catalog.
url: https://raw.githubusercontent.com/api-evangelist/novira-therapeutics/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- canaan-partners
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-20'
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Hepatitis B
- Antivirals
- Acquired
apis: []
x-enrichment:
  date: '2026-07-20'
  status: nochange
  artifacts_added: 0
  pass: local-v1
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io